Human Microbiome Market Set to Surge from USD 0.77 Billion to USD 1.65 Billion by 2028, Finds New Research

Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Human Microbiome Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to's offering.

The human microbiome is increasingly recognized for its critical role in human health, influencing everything from disease resistance to metabolic processes. A recent market analysis highlights trends, shares, and forecasts within this burgeoning sector, projecting substantial growth from USD 0.77 billion in 2023 to an impressive USD 1.65 billion by 2028. The compounded annual growth rate (CAGR) is predicted to be an impressive 16.37% during the 2023-2028 forecast period.

Market Dynamics Influencing Growth

Several key factors are propelling the human microbiome market forward. The market is gaining momentum from heightened awareness and research studies that delve into the microbiome's notable effects on lung and respiratory health, specifically in light of the global COVID-19 pandemic. The ongoing increase in lifestyle-related diseases and an aging population also contribute to market expansion. Crucially, public and private sector funding fortifies research within this field, adding vigor to market projections.

Therapeutic Applications Show High Market Potential

With a broad spectrum of potential applications from combatting COVID-19 to addressing diabetes, therapeutic applications within the human microbiome sector are showing considerable promise. This traction is fueled by intensive research to unveil further therapeutic applications and by an overall increasing demand to treat chronic diseases.

North American Market Leads in Development and Growth

North America currently holds dominance in the market due to an increasing incidence of lifestyle disorders and strong pipeline of therapeutic solutions. A surge in disease prevalence across the region corroborates the growing investment and research focus on the human microbiome. Advancements in regulatory approvals further nourish market growth in this region, setting the stage for significant impact and innovation.

Competitive Landscape and Industry Movements - Key Players Advancing Therapeutic Pipeline

The market landscape for human microbiome therapeutics is both competitive and collaborative, with key players investing in the development of new, safe, and effective drugs. Strategic alliances and a focus on innovation are central to the endeavors of companies actively operating in the space.

Additional Insights and Analyst Support

  • Extensive research and comprehensive analyses underpin the market estimates.
  • Analyst support offers an additional layer of insight for market participants.

This new research underscores the immense potential of the human microbiome market, highlighting its significant growth prospects and the industry impacts expected over the coming years. As scientists further understand the crucial relationship between the microbiome and human health, the sector is poised for transformative advancements in therapeutic applications and overall healthcare practices.

A selection of companies mentioned in this report includes

  • AOBiome
  • Astarte Medical
  • Axial Biotherapeutics, Inc.
  • DuPont
  • Enterome
  • Evelo Biosciences Inc
  • Finch Therapeutics Group Inc.
  • Ginkgo Bioworks
  • Exeliom Biosciences SAS
  • Osel Inc.
  • Second Genome Inc.
  • Seres Therapeutics

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Human Microbiome Market Estimated Number Of People With Diabetes In Millions Globally 2020 2045 Human Microbiome Market Human Microbiome Market Growth Rate By Region

Contact Data